You are here : Home > Scientific news > BMP9 a new endothelial quiescent factor

Highlight | Cancer | Genetic diseases

BMP9 a new endothelial quiescent factor


​​Angiogenesis is the formation of new blood vessels from existing blood system. Tumors promote their own vascularization. The understanding of the mechanisms that regulate angiogenesis and the identication of the key molecules involved should allow to identify new therapeutic targets in order to combat and control angiogenesis and therefore cancer. Such a molecule was characterized by a team at the Cancer Biology and Infection laboratory that inhibits the neo-angiogenesis. This molecule, BMP9, therefore representes an important tool in the pathologies where angiogenesis is implicated as in the cancer.​​

Published on 1 July 2008

 ​​

Top page